Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost

Vaccine. 2007 Apr 12;25(15):2951-8. doi: 10.1016/j.vaccine.2006.05.081. Epub 2006 Jun 9.

Abstract

Here, we conduct dose-response studies in mice for the elicitation of CD8 T cells by a DNA vaccine that expresses HIV Gag. For DNA doses ranging from 1 to 100 microg, the studies revealed greater than 10-fold increases in anti-Gag CD8 T cells following a DNA prime or a DNA prime and a constant modified vaccinia Ankara (MVA) boost. These results are in contrast to dose-response studies for MVA vectors expressing Gag, where only 2-3-fold increases in anti-Gag CD8 T cells were elicited by 100-fold increases in dose.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • CD8-Positive T-Lymphocytes / immunology*
  • Dose-Response Relationship, Immunologic
  • Female
  • HIV Core Protein p24 / genetics
  • HIV Core Protein p24 / immunology
  • Mice
  • Mice, Inbred BALB C
  • Vaccines, DNA / administration & dosage
  • Vaccines, DNA / genetics
  • Vaccines, DNA / immunology*
  • Vaccinia virus / immunology*

Substances

  • HIV Core Protein p24
  • Vaccines, DNA